Pharmaco-epidemiology: What do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions?
- 1 August 2004
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 185 (2), 93-94
- https://doi.org/10.1192/bjp.185.2.93
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Differences between clinical trials and postmarketing useBritish Journal of Clinical Pharmacology, 2003
- Are psychostimulant drugs being used appropriately to treat child and adolescent disorders?The British Journal of Psychiatry, 2003
- Do Hypertension and Diuretic Treatment in Pregnancy Increase the Risk of Schizophrenia in Offspring?American Journal of Psychiatry, 2003
- The early detection and treatment controversy in schizophrenia researchCurrent Opinion in Psychiatry, 2003
- A Population-Based Study of Measles, Mumps, and Rubella Vaccination and AutismNew England Journal of Medicine, 2002
- Prescribing Second-Generation Antipsychotics and the Evolving Standard of Care in ItalyPharmacopsychiatry, 2002
- MMR vaccination and autism: is there a link?Expert Opinion on Drug Safety, 2002
- Selling sickness: the pharmaceutical industry and disease mongering * Commentary: Medicalisation of risk factorsBMJ, 2002
- Benzodiazepine use and risk of dementiaA nested case–control studyJournal of Clinical Epidemiology, 2002
- Antidepressant use in clinical practice: efficacy v. effectivenessThe British Journal of Psychiatry, 2001